CORYNEBACTERIUM-PARVUM - IMMUNOMODULATION IN LOCAL BACTERIAL-INFECTIONS
- 1 January 1980
- journal article
- research article
- Vol. 87 (1) , 52-58
Abstract
Inoculation with C. parvum 14 days before bacterial challenge produced protection against murine-simulated surgical wound infection with Escherichia coli to the same degree as was provided by BCG pretreatment. Simulated surgical wound infection induced by Staphylococcus aureus in mice followed a much more variable course; bacterial growth was depressed 7 days after C. parvum inoculation and was equivocal at a 14 day interval. Unlike E. coli infection modified by C. parvum or BCG, bacterial growth was significantly enhanced when the interval between C. parvum inoculation and S. aureus challenge was 20 or 28 days. Explanations for these differences and their possible clinical relevance are discussed.This publication has 5 references indexed in Scilit:
- Intravenous corynebacterium parvum. An adjunct to chemotherapy for resistant advanced ovarian cancerCancer, 1977
- Effect of Sensitization with Propionibacterium Acnes on the Growth of Listeria Monocytogenes and Treponema Pallidum in RabbitsThe Journal of Immunology, 1977
- Complement activation in vivo in cancer patients receiving C. parvum immunotherapyBritish Journal of Cancer, 1976
- Observations followingCorynebacterium parvum administration to patients with advanced malignancy.A phase I studyCancer, 1976
- THE EFFECT OF MYCOBACTERIUM-TUBERCULOSIS (BCG) INFECTION ON THE RESISTANCE OF MICE TO BACTERIAL ENDOTOXIN AND SALMONELLA-ENTERITIDIS INFECTION1959